So many women in perimenopause get handed an iron supplement and sent home, only to feel no better six months later. That happened because nobody checked whether the problem was actually iron — or B12, or inflammation, or something else entirely. The blood test that catches this is simple. The frustration of not getting it is enormous.
Learn more about Rose →Irregular, prolonged, or flooding periods are among the most common experiences of perimenopause, and they can drain iron stores faster than diet alone can replenish them. The body's entire ferritin reserve can be depleted over months of heavy cycles even when red blood cell counts still look borderline normal — meaning many women are functionally iron-depleted long before a standard CBC flags it. Treatment here is direct iron repletion, but the underlying bleeding pattern also needs addressing, often through hormonal or non-hormonal management of the cycles themselves.
Iron absorption depends heavily on stomach acid, and gastric acid production naturally declines with age — a process that accelerates for many women in their 40s and 50s. Women taking proton pump inhibitors for reflux (itself more common in perimenopause) face an additional layer of impaired absorption, meaning oral iron supplements may have limited effectiveness regardless of dose. In these cases, addressing the absorption barrier — sometimes through IV iron infusion or switching supplement form — matters more than simply increasing the oral dose.
B12 absorption requires a protein called intrinsic factor, produced by the stomach lining, and intrinsic factor production decreases with age-related gastric atrophy — a process that can become clinically significant from midlife onward. The resulting megaloblastic anemia produces large, poorly functioning red blood cells and is often accompanied by neurological symptoms like tingling, memory difficulties, and mood changes that are easily attributed to menopause itself. Oral B12 supplements are often insufficient when intrinsic factor is the problem; sublingual, intramuscular, or high-dose oral forms that bypass the intrinsic factor pathway are typically required.
Folate deficiency produces a clinically similar picture to B12 deficiency — large, immature red blood cells and significant fatigue — but the cause and treatment are distinct. Common medications used by midlife women, including methotrexate for autoimmune conditions and certain anticonvulsants, can interfere with folate metabolism directly. Critically, supplementing folate in the presence of undiagnosed B12 deficiency can mask the B12 problem on blood tests while the neurological damage continues, which is why both should always be checked together.
Low-grade systemic inflammation — which increases in the perimenopause transition partly due to declining estrogen's anti-inflammatory role — can produce a functional anemia where iron is actually present in the body but locked away and unavailable to make red blood cells. This is mediated by a hormone called hepcidin, which rises with inflammation and effectively traps iron in storage. Giving iron supplements to someone with anemia of chronic inflammation does very little and can create oxidative stress; the underlying inflammatory condition needs to be identified and treated first.
Hypothyroidism — which becomes significantly more prevalent in women over 40 — can cause anemia through multiple mechanisms, including reduced red blood cell production, impaired iron absorption, and, when combined with heavy periods, accelerated iron loss. The anemia often looks like mild iron deficiency on a basic panel, leading to iron supplementation that produces little improvement because the thyroid is the root problem. Treating the hypothyroidism typically resolves or substantially improves the anemia, though concurrent iron or B12 deficiency may also need correction.
Several autoimmune conditions that cause the immune system to destroy red blood cells — including autoimmune hemolytic anemia and conditions like lupus — are estrogen-sensitive and can flare or newly emerge during the hormonal fluctuations of perimenopause. Unlike deficiency anemias, hemolytic anemia produces an elevated bilirubin and reticulocyte count as the body tries to compensate, and a standard iron panel will be unhelpful or misleading. Treatment is immunosuppressive and entirely different from nutritional approaches, making correct diagnosis essential before any treatment begins.
Celiac disease has a well-documented second peak of diagnosis in women in their 40s and 50s, partly because hormonal changes can unmask latent autoimmune conditions and partly because it frequently goes undiagnosed for decades. Intestinal damage from celiac disease impairs absorption of iron, B12, and folate simultaneously, producing a complex mixed anemia that responds poorly to any single supplement. A gluten-free diet that allows intestinal healing is the cornerstone of treatment — supplementation without dietary change is largely ineffective.
Several medications that midlife women are commonly prescribed can cause or worsen anemia through different mechanisms — NSAIDs and aspirin can cause chronic low-level gastrointestinal bleeding that depletes iron silently, metformin impairs B12 absorption over time, and some blood pressure medications can suppress red blood cell production. Because these effects develop gradually over months or years, the connection to a medication started years earlier is frequently missed. A medication review looking specifically at anemia risk is a worthwhile step before embarking on supplementation, since the cause is ongoing as long as the drug continues.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.